report
GenAI healthcare startup investments surge amidst funding drop
GenAI healthcare startup investments surge amidst funding drop
Venture capital deals related to the technology stood at $447m in H1.
What lies ahead for the global 3D printing medical devices market?
One driving factor is the adoption of bioprinting to produce artificial living tissues.
Join the community
Most Read
1. China’s pharma growth shifts from drugs to high-tech manufacturing 2. Why China's pharma market is now a consumer game 3. St. Andrew’s Community Hospital opens second facility in Bedok South 4. China's licensing boom reshapes global pharma power 5. Australian gov’t allocates $970,000 to sustain cohealth GP servicesResource Center
Awards
Mar
26
Events
Event News
Healthcare
China's licensing boom reshapes global pharma power
Record-breaking BD deals reflect Beijing's innovative assets are gaining massive international recognition.